News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
243 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (22652)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (119)
3 (12)
4 (242)
5 (269)
6 (241)
7 (243)
8 (78)
9 (2)
10 (3)
11 (232)
12 (312)
13 (213)
14 (243)
15 (110)
16 (8)
17 (9)
18 (85)
19 (267)
20 (246)
21 (243)
22 (113)
23 (7)
24 (12)
25 (220)
26 (276)
27 (239)
28 (312)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Business
Atox Bio Announces Appointment of Robert Greif as Chief Commercial Officer
In this newly created position, Robert will be responsible for building the commercial organization and pre-commercial activities for Reltecimod
February 14, 2019
·
4 min read
Business
PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2018 Financial Results
PTC Therapeutics, Inc. announced that the Company will host a webcast conference call to report its fourth quarter and year end 2018 financial results and provide an update on the company’s business and outlook on Thursday, February 28, 2019 at 4:30 p.m. after closing of the market.
February 14, 2019
·
1 min read
Business
CCRM Announces Partnership with Family Equality Council to Offer Industry-Leading Fertility Outcomes to the LGBTQ Community
Global pioneer in fertility science, research and treatment teams up with nation’s leading organization for LGBTQ families to become a leader in inclusive fertility healthcare in North America
February 14, 2019
·
3 min read
FDA
Foldax, Inc. Gains Approval to Begin US Clinical Trials of the First and Only Biopolymer Heart Valve Platform
FDA has granted IDE approval to begin an Early Feasibility Study of the Tria surgical aortic heart valve for the treatment of aortic valve disease.
February 14, 2019
·
2 min read
Business
360° Impact Health Program Founded by Elena Wilkins Helps Women Resolve Hormonal Challenges
If you’ve already tried everything to cure your chronic thyroid or hormone disorder without success, here are the four keys that returned Elena Wilkins to vibrant health, and could work for you, too.
February 14, 2019
·
4 min read
Business
Magnolia Medical Appoints Matthew Lehr as Intellectual Property Special Counsel
Matthew B. Lehr has been named Intellectual Property Special Counsel and will advise the company on intellectual property (IP) strategy and enforcement matters.
February 14, 2019
·
2 min read
Lone Star Bio
ESO and Prehospital Care Research Forum at UCLA Partner for ESO Research Forum at Wave Conference
Registration open for EMS professionals to join forces with clinical leaders, researchers and data analysts to undertake real-world projects aimed at improving community health and safety through the power of data
February 14, 2019
·
3 min read
Genetown
Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia
Participation from Johnson & Johnson Innovation – JJDC, Novartis Institutes for BioMedical Research, Osage University Partners, and Vor Co-founder PureTech Health
February 14, 2019
·
3 min read
Burning Rock announces the completion of the Series C financing of RMB 850 million and strives to build an international leading tumor precision medicine brand
On February 14, 2019, Burning Rock held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 million.
February 14, 2019
·
6 min read
Business
Ipsen Delivers Strong 2018 Results and Expects Continued Sales and Profit Growth in 2019
Ipsen, a global specialty-driven biopharmaceutical group, today announced its financial results for the full year 2018.
February 14, 2019
·
45 min read
Previous
24 of 25
Next